Topic: Eye Care
Under considerable pressure from the Federal Trade Commission, Novartis is readying to sell Miochol-E to competitor Bausch & Lomb. Novartis had to csell the drug before the FTC would approve its aquisition of Alcon. Why? Both companies made the only injectable miotics, which physicians use in cataract surgery.That's the report from Business Week.
